Skip to main content

Table 2 Treatment details, n = 42

From: A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience

  

N = 42

Median dose prescribed to the whole pelvis (Gy)

 

30.6 (range, 26–50.4)

Median brachytherapy fractions (n)

 

4 (range, 2–5)

Median volume of HR-CTV at initial HBT (ml)

 

37.1 (range, 12.1–89.2)

Median HR-CTV D90 in EQD2 (Gy)

 

70.3 (range, 56.2–97.3)

Median HR-CTV V100 (%)

 

95.9 (range, 79.3–100)

Median HR-CTV V150 (%)

 

57.7 (range, 39.1–89.4)

Median HR-CTV V200 (%)

 

29.9 (range, 19.6–58.5)

Median dose of bladder D2cc in EQD2 (Gy)

 

72.4 (range, 60.7–87.2)

Median dose of rectum D2cc in EQD2 (Gy)

 

64.5 (range, 47.6–75.2)

Concurrent chemotherapy

Yes

28

No

14